BioAtla (BCAB) Non Operating Interest Expenses (2020 - 2026)

BioAtla (BCAB) has reported Non Operating Interest Expenses for 5 consecutive years, with $11000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Interest Expenses changed N/A year-over-year to $11000.0; the trailing twelve-month figure through Jun 2026 stood at $34000.0 (up 325.0% YoY), and the FY2021 full-year result was $3000.0, down 99.78% from the prior year.
• Non Operating Interest Expenses slipped to $11000.0 in Q2 2026 per BCAB's latest filing, from $20000.0 in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $20000.0 in Q1 2026 and bottomed at $3000.0 in Q3 2025.
• Historically, Non Operating Interest Expenses has averaged $10500.0 across 3 years, with a median of $9500.0 in 2024.
• The widest YoY moves for Non Operating Interest Expenses: up 62.5% in 2025, down 62.5% in 2025.
• Over 3 years, Non Operating Interest Expenses stood at $8000.0 in 2024, then plunged by 62.5% to $3000.0 in 2025, then jumped by 266.67% to $11000.0 in 2026.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $11000.0, $20000.0, and $3000.0 for Q2 2026, Q1 2026, and Q3 2025 respectively.